Chuck Royce's PTGX Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 16,989 shares of Protagonist Therapeutics, Inc. (PTGX) worth $1.48 M, representing 0.02% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Chuck Royce has maintained this position in PTGX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 4,734 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Protagonist Therapeutics (PTGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Protagonist Therapeutics (PTGX) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +4,734 | Add 38.63% | 16,989 | $66.43 |
| Q1 2025 | +12,255 | New Buy | 12,255 | $48.36 |
Chuck Royce's Protagonist Therapeutics Investment FAQs
Chuck Royce first purchased Protagonist Therapeutics, Inc. (PTGX) in Q1 2025, acquiring 12,255 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Protagonist Therapeutics, Inc. (PTGX) for 4 quarters since Q1 2025.
Chuck Royce's largest addition to Protagonist Therapeutics, Inc. (PTGX) was in Q1 2025, adding 12,255 shares worth $592,652.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 16,989 shares of Protagonist Therapeutics, Inc. (PTGX), valued at approximately $1.48 M.
As of the Q4 2025 filing, Protagonist Therapeutics, Inc. (PTGX) represents approximately 0.02% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Protagonist Therapeutics, Inc. (PTGX) was 16,989 shares, as reported at the end of Q3 2025.